Droseffik 0.02 mg - 3 mg film-coat. tabl.

País: Bèlgica

Idioma: anglès

Font: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ingredients actius:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Disponible des:

EFFIK Benelux SA-NV

Codi ATC:

G03AA12

Designació comuna internacional (DCI):

Drospirenone; Ethinylestradiol; Placebo

Dosis:

0,02 mg - 3 mg

formulario farmacéutico:

Film-coated tablet

Composición:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Vía de administración:

Oral use

Área terapéutica:

Drospirenone and Ethinylestradiol

Resumen del producto:

CTI code: 428407-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-02 - Pack size: 2 x 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224122 - CNK code: 2995744 - Delivery mode: Medical prescription; CTI code: 428407-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224139 - CNK code: 2995751 - Delivery mode: Medical prescription; CTI code: 428407-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224146 - CNK code: 2995769 - Delivery mode: Medical prescription

Estat d'Autorització:

Commercialised: Yes

Data d'autorització:

2012-10-05